Celebrating 30 years of excellence, DIA’s Advertising and Promotions Regulatory Affairs Conference will continue to offer a comprehensive agenda covering the latest updates in the ad promo regulatory space. Industry experts will share best practices for ad promo launch strategies, discuss global ad promo review considerations, and evaluate how clinical trial design impacts promotional practice. Hear from pioneers in the industry on the latest OPDP draft guidance and initiatives, enforcement actions, social science research, and electronic Common Technical Document (eCTD) submission process.
The conference delivers an overview of the current and future state of advertising and promotion, featuring perspectives from medical marketing agencies, regulatory, medical and legal professionals. Whether you are new to the field or have years of experience, you can't afford to miss this opportunity to prepare yourself for what’s coming!
Program Update! FDA publishes 2 final guidances that provide greater clarity about their thinking and recommendations for certain medical product communications. Register to learn how these are being incorporated into the 2019 program.
Professional Showcase Call for Abstracts
The Program Committee welcomes poster abstract submissions for DIA’s Advertising and Promotion Regulatory Affairs Conference. This Call for Abstracts is an opportunity for professionals to submit innovative and/or relevant ideas, methods, and best practices related to the advertising and promotion space.
Guidelines | Submit
Deadline: December 14
Who should attend?
Professionals in pharmaceutical, biologics, and medical device companies involved in:
- Regulatory Affairs
- Medical Information and Affairs
- Senior Management
Micheline Awad, MBA • Director Regulatory Affairs, Advertising and Promotion
Neurocrine Biosciences, Inc., United States
Glenn N. Byrd, MBA, RAC • Senior Director, Oncology Promotional Regulatory Affairs
AstraZeneca, United States
Dale Cooke, MA • President
PhillyCooke Consulting , United States
Mark Gaydos • VP, NA General Medicines/US Advertising and Promotion, Global Regulatory Affairs
Sanofi, United States
Sheetal Patel, PharmD • Head, Regulatory Advertising and Promotion
Johnson & Johnson International, United States
Michele Sharp, PharmD • Senior Director, Global Regulatory Affairs
Eli Lilly and Company, United States
Thomas W. Abrams, MBA • Director, Office of Prescription Drug Promotion, OMP, CDER
FDA, United States
Wayne L. Pines • President, Regulatory Services and Healthcare
APCO Worldwide Inc., United States
Lucy Rose, MBA • President
Lucy Rose and Associates, LLC, United States